The successful and well-attended “Nonclinical to Clinical Translation of Antibody-Drug Conjugates” Workshop Session at the 2018 Annual Meeting and ToxExpo highlighted the challenges in nonclinical to clinical translatability of ADCs and regulatory considerations based on ICH S9.
This session during the 2018 Annual Meeting had many good talks about exposure to nerve agents, identification of new biomarkers, and translation from in vitro testing to approved products and treatments to help address human poisoning.
Attend these webinars in February.
A February 14 webinar will explore the transition of both trainee scientists and established investigators from basic science-centered projects to those driven by clinical and translational toxicology.
During a workshop session titled "Systems Toxicology: The Final Goal of the Emerging New Approach Methods," I laughed, learned, and literally cried, as Thomas Hartung discussed his personal experiences and work with "mini-brains."